Dalmia Healthcare starts clinical trial of Astha-15 for COVID-19 treatement

▴ dalmia-healthcare-starts-third-stage-trials-astha-15-ayurvedic
"Astha-15" acts as a bronchodilator, decongestant, anti-inflammatory lung detoxifier without any side-effects

Dalmia Healthcare, the healthcare division of Dalmia Group led by renowned industrialist Sanjay Dalmia, starts clinical trial to evaluate the efficacy and safety of polyherbal combination "Astha-15" for treatment of COVID-19. The Dalmia Centre for Research and Development (DCRD), R&D entity of Dalmia Group after years of extensive research, manufactured a polyherbal combination of 15 herbs called Astha-15, also mentioned in the Indian System of Medicine. Set regulatory guidelines of Informed Consent Declaration, Insurance Terms and EC approvals will be followed to conduct the Multi-centric, Phase III clinical trials.

The study comes in the back of the Ministry of AYUSH last month recommending the use of herbal products like tea, spices, to overcome the pandemic. The polyherbal combination "Astha-15", made available by the Group on March 16, has previously undergone a randomized double-blind, placebo-controlled study on patients, in speciality Govt. Hospital, Chennai, India. As per the double-blind study, the drug acts as a bronchodilator, decongestant, anti-inflammatory, lung detoxifier and didn't show any side-effects. Now this polyherbal combination "Astha-15" will undergo a phase III clinical trial with the most primary COVID-19 sites across India under the supervision of highly skilled physicians.

"We are conducting Human trials of our highly efficient Ayurvedic composition which can potentially help in curing COVID-19 patients. Successful human trials of our medicine will not only curtail the impact of the contagious virus all across the world but will also establish supremacy of Ayurveda, our ancient system of medicine over any other methods of healthcare," said Mr. Sanjay Dalmia, Chairman, Dalmia Group of Companies.

Dalmia Healthcare Limited (DHL), a Dalmia Group Company, has made foray into the healthcare business in the year 2000 and offers plant-based formulations (Ayurvedic/herbal) prepared through scientific validation followed by clinical trials undertaken by its research centre, Dalmia Centre for Research and Development (DCRD).

The essence of pre-marketing efforts focuses on clinical trials compared and measured with those for various Allopathic drugs indicated for similar conditions. Extensive toxicological studies are conducted while formulating DHL products in order to ensure that the products are safe and devoid of adverse side-effects. All products of Dalmia Healthcare are manufactured and evaluated in accordance with the standards of modern medical parameters.

Tags : #DalmiaHealthcare #AyushMinistry #SanjayDalmia #Astha-15

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024
Empowering Patients: The Role of Advocacy in Indian HealthcareMarch 26, 2024
A New Dawn in Heart Surgery: Mitral Valve Repair for 15-Year-Old PatientMarch 26, 2024